OBD — Oxford Biodynamics Income Statement
0.000.00%
Last trade - 00:00
- £28.04m
- £29.22m
- £0.51m
2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.907 | 0.456 | 0.341 | 0.154 | 0.51 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 0.116 | 0.266 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.63 | 5.41 | 7.85 | 8.76 | 10.6 |
Operating Profit | -3.72 | -4.95 | -7.51 | -8.6 | -10.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.39 | -4.95 | -7.63 | -7.57 | -11.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.8 | -4.35 | -6.68 | -6.71 | -10.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.8 | -4.35 | -6.68 | -6.71 | -10.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.8 | -4.35 | -6.68 | -6.71 | -10.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.03 | -0.047 | -0.072 | -0.067 | -0.074 |